nublast TEMOZOLOMIDE
Introduction to nublast
Nublast is a medication available in tablet form, primarily used to treat certain aggressive brain tumors. Nublast is effective in managing conditions such as glioblastoma multiforme and anaplastic astrocytoma, which are types of cancer affecting the brain.
Composition of nublast
Nublast contains the active ingredient Temozolomide, which belongs to a class of drugs known as alkylating agents. These agents work by adding an alkyl group to the DNA of cancer cells, causing damage that prevents the cells from growing and dividing.
Uses of nublast
- Treatment of glioblastoma multiforme
- Treatment of anaplastic astrocytoma
Side effects of nublast
- Common side effects: nausea, vomiting, fatigue
- Serious side effects: lowered blood cell counts, increased risk of infection
Precautions of nublast
Patients taking nublast should be aware that it can lower blood cell counts, increasing the risk of infections. It is not recommended for use during pregnancy due to potential harm to the unborn baby. Patients with severe bone marrow suppression should avoid using nublast.
How to Take nublast
Nublast is typically taken orally, in tablet form, on an empty stomach. It is usually prescribed at a starting dose of 150 mg/m² once daily for five days in a 28-day cycle. It should be taken either one hour before or two hours after a meal, following your doctor's specific instructions.
Conclusion of nublast
Nublast, containing the active ingredient Temozolomide, is a part of the alkylating agents therapeutic class. It is primarily used to treat aggressive brain tumors such as glioblastoma multiforme and anaplastic astrocytoma. Manufactured with precision, nublast offers a targeted approach to cancer treatment. Always consult your healthcare provider for personalized advice and follow their guidance for optimal results with nublast.
Available in 3 variations

strip of 5 capsules

strip of 5 capsules

strip of 5 capsules